You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
At The Conversation, the University of Birmingham's Nick Loman writes about his group's efforts to bring genome sequencing and surveillance to disease outbreak sites.
In Nature this week: genetic variation in Sierra Leone Ebola virus, host adaptation in microsporidian pathogens, and more.
Xpert Ebola joins three other tests on the World Health Organization's list of in vitro diagnostics eligible for procurement in Ebola-affected countries.
Genome sequencing on almost 200 Ebola virus isolates from Sierra Leone pointed to a jump in genetic diversity in the virus from July to October of 2014.
Researchers plan to share Ebola and MERS viral sequence data more quickly.
The system uses off-the-shelf laboratory components and currently runs an Ebola assay based on isothermal amplification chemistry from Alere subsidiary TwistDx.
The Wall Street Journal profiles NewLink Genetics, a biotech company based in Iowa.
A new analysis indicates that the Ebola virus behind the current West African outbreak is mutating at about the same rate as other Ebola viruses.
The self-contained, cartridge-based test runs on the firm's GeneXpert system.
The study is being conducted in Sierra Leone by the University of Oxford.
The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.
Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.
A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.
In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.